Literature DB >> 34595272

Xenograft Mouse Model of Human Uveal Melanoma.

Yao Chen1,2, Xiao Liu1,3, Ling Gao1, Yongqing Liu3.   

Abstract

Uveal melanoma (UM) is a malignant intraocular tumor in adults. Metastasis develops in almost half of the patients and over 90% of the metastases are in the liver. With the advances in molecular targeting therapy for melanoma, a proper metastasis animal model is of increasing importance for testing the accuracy and effectiveness of systemic therapies. Here, we describe a xenograft model for mimicking human UM liver metastasis by injecting human UM cells into the vitreous cavity in nude mice. The athymic nude mice are immunocompromised and suitable for xenograft tumor growth and metastasis, and intravitreal injection of cells is a quicker and easier operation under a binocular scope, thereby it is simple and effective to test human UM growth and metastasis.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Human uveal melanoma; Intravitreal injection; Liver metastasis; Ocular tumor growth; Xenograft mouse model

Year:  2017        PMID: 34595272      PMCID: PMC8438462          DOI: 10.21769/BioProtoc.2594

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  21 in total

1.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 2.  Estimating prognosis for survival after treatment of choroidal melanoma.

Authors:  Bertil Damato; Antonio Eleuteri; Azzam F G Taktak; Sarah E Coupland
Journal:  Prog Retin Eye Res       Date:  2011-05-30       Impact factor: 21.198

3.  A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

Authors:  J William Harbour; Daniel L Chao
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

Review 4.  Metastatic uveal melanoma: biology and emerging treatments.

Authors:  Scott E Woodman
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

5.  Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.

Authors:  Jenny Li-Ying Huang; Oscar Urtatiz; Catherine D Van Raamsdonk
Journal:  Cancer Res       Date:  2015-06-25       Impact factor: 12.701

Review 6.  Uveal Melanoma Treatment and Prognostication.

Authors:  Mehmet Dogrusöz; Martine J Jager; Bertil Damato
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2017 Mar-Apr

Review 7.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

8.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 9.  GNAQ and GNA11 mutations in uveal melanoma.

Authors:  Alexander N Shoushtari; Richard D Carvajal
Journal:  Melanoma Res       Date:  2014-12       Impact factor: 3.599

Review 10.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.